Header Logo

Connection

Yahya Choonara to Humans

Back to Details
This is a "connection" page, showing publications Yahya Choonara has written about Humans.
Yahya Choonara
Connection Strength
2,693
Humans
  1. The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives. Wound Repair Regen. 2025 Jan-Feb; 33(1):e13251.
    View in: PubMed
    Score: 0,073
  2. Extracellular nanovesicles as neurotherapeutics for central nervous system disorders. Expert Opin Drug Deliv. 2025 Jan; 22(1):69-84.
    View in: PubMed
    Score: 0,073
  3. Pulmonary drug delivery devices and nanosystems as potential treatment strategies for acute respiratory distress syndrome (ARDS). Int J Pharm. 2024 May 25; 657:124182.
    View in: PubMed
    Score: 0,070
  4. A review of hyaluronic acid-based therapeutics for the treatment and management of arthritis. Int J Biol Macromol. 2024 Apr; 264(Pt 2):130645.
    View in: PubMed
    Score: 0,069
  5. Co-emulsified Alginate-Eudragit Nanoparticles: Potential Carriers for Localized and Time-defined Release of Tenofovir in the Female Genital Tract. AAPS PharmSciTech. 2024 Jan 10; 25(1):15.
    View in: PubMed
    Score: 0,068
  6. Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma. ACS Appl Bio Mater. 2023 07 17; 6(7):2747-2759.
    View in: PubMed
    Score: 0,066
  7. In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer. AAPS PharmSciTech. 2023 May 24; 24(5):123.
    View in: PubMed
    Score: 0,065
  8. Long-acting vaccine delivery systems. Adv Drug Deliv Rev. 2023 07; 198:114897.
    View in: PubMed
    Score: 0,065
  9. A 3D-Printed Biomaterial Scaffold Reinforced with Inorganic Fillers for Bone Tissue Engineering: In Vitro Assessment and In Vivo Animal Studies. Int J Mol Sci. 2023 Apr 20; 24(8).
    View in: PubMed
    Score: 0,065
  10. Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis. Biomed Pharmacother. 2023 Jun; 162:114588.
    View in: PubMed
    Score: 0,065
  11. Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. J Pharm Sci. 2023 06; 112(6):1566-1585.
    View in: PubMed
    Score: 0,064
  12. Can Nanomedicinal Approaches Provide an Edge to the Efficacy of Tyrosine Kinase Inhibitors? Curr Med Chem. 2023; 30(13):1482-1501.
    View in: PubMed
    Score: 0,063
  13. Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery. Curr Drug Deliv. 2023; 20(10):1487-1503.
    View in: PubMed
    Score: 0,063
  14. Advances in Stimuli-responsive Hydrogels for Tissue Engineering and Regenerative Medicine Applications: A Review Towards Improving Structural Design for 3D Printing. Curr Pharm Des. 2023; 29(40):3187-3205.
    View in: PubMed
    Score: 0,063
  15. Customized 3D printed multi-drug systems: an effective and efficient approach to polypharmacy. Expert Opin Drug Deliv. 2022 09; 19(9):1149-1163.
    View in: PubMed
    Score: 0,062
  16. A review on engineered magnetic nanoparticles in Non-Small-Cell lung carcinoma targeted therapy. Int J Pharm. 2021 Sep 05; 606:120870.
    View in: PubMed
    Score: 0,057
  17. Advanced Strategies for Tissue Engineering in Regenerative Medicine: A Biofabrication and Biopolymer Perspective. Molecules. 2021 Apr 26; 26(9).
    View in: PubMed
    Score: 0,057
  18. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865.
    View in: PubMed
    Score: 0,056
  19. Visible light-curable water-soluble chitosan derivative, chitosan hydrogel, and preparation method: a patent evaluation of US2019202998A1. Expert Opin Ther Pat. 2021 May; 31(5):351-360.
    View in: PubMed
    Score: 0,056
  20. Fabrication and Characterisation of a Photo-Responsive, Injectable Nanosystem for Sustained Delivery of Macromolecules. Int J Mol Sci. 2021 Mar 25; 22(7).
    View in: PubMed
    Score: 0,056
  21. Synthesis and Properties of CurNQ for the Theranostic Application in Ovarian Cancer Intervention. Molecules. 2020 Sep 29; 25(19).
    View in: PubMed
    Score: 0,054
  22. Improving drug delivery technology for treating neurodegenerative diseases. Expert Opin Drug Deliv. 2016 07; 13(7):1029-43.
    View in: PubMed
    Score: 0,040
  23. 3D-printing and the effect on medical costs: a new era? Expert Rev Pharmacoecon Outcomes Res. 2016; 16(1):23-32.
    View in: PubMed
    Score: 0,039
  24. Five decades of sci-fi in drug delivery. Ther Deliv. 2013 Mar; 4(3):285-7.
    View in: PubMed
    Score: 0,032
  25. Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers. Colloids Surf B Biointerfaces. 2011 Oct 15; 87(2):243-54.
    View in: PubMed
    Score: 0,028
  26. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos. 2011 May; 32(4):185-209.
    View in: PubMed
    Score: 0,028
  27. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci. 2010 May; 99(5):2219-39.
    View in: PubMed
    Score: 0,026
  28. Advances in the treatment of neurodegenerative disorders employing nanotechnology. Ann N Y Acad Sci. 2010 Jan; 1184:154-72.
    View in: PubMed
    Score: 0,026
  29. Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS. Adv Drug Deliv Rev. 2010 Mar 18; 62(4-5):532-46.
    View in: PubMed
    Score: 0,026
  30. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders. Int J Mol Sci. 2009 Jun 03; 10(6):2510-57.
    View in: PubMed
    Score: 0,025
  31. Mechanistic evaluation of alginate-HEC gelisphere compacts for controlled intrastriatal nicotine release in Parkinson's disease. J Pharm Sci. 2009 Jun; 98(6):2059-72.
    View in: PubMed
    Score: 0,025
  32. Advances in the treatment of Parkinson's disease. Prog Neurobiol. 2007 Jan; 81(1):29-44.
    View in: PubMed
    Score: 0,021
  33. An in vitro study of the design and development of a novel doughnut-shaped minitablet for intraocular implantation. Int J Pharm. 2006 Mar 09; 310(1-2):15-24.
    View in: PubMed
    Score: 0,020
  34. The Role of Artificial Intelligence and Machine Learning in Accelerating the Discovery and Development of Nanomedicine. Pharm Res. 2024 Dec; 41(12):2289-2297.
    View in: PubMed
    Score: 0,018
  35. Sodium alginate/carboxymethylcellulose gel formulations containing Capparis sepieria plant extract for wound healing. Ther Deliv. 2024; 15(12):921-937.
    View in: PubMed
    Score: 0,018
  36. Electrospun nanofibrous scaffolds as a platform to reduce melanoma tumour growth, recurrence, and promote post-resection wound repair. Biomater Adv. 2024 Jul; 161:213870.
    View in: PubMed
    Score: 0,017
  37. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Lancet Infect Dis. 2023 08; 23(8):e288-e300.
    View in: PubMed
    Score: 0,016
  38. Dissolvable sodium alginate-based antibacterial wound dressing patches: Design, characterization, and in vitro biological studies. Int J Biol Macromol. 2023 Mar 31; 232:123460.
    View in: PubMed
    Score: 0,016
  39. Synthesis and Cytotoxic Activity of 1,2,4-Triazolo-Linked Bis-Indolyl Conjugates as Dual Inhibitors of Tankyrase and PI3K. Molecules. 2022 Nov 07; 27(21).
    View in: PubMed
    Score: 0,016
  40. Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches. Expert Opin Drug Deliv. 2022 07; 19(7):771-793.
    View in: PubMed
    Score: 0,015
  41. Advances in designing of polymeric micelles for biomedical application in brain related diseases. Chem Biol Interact. 2022 Jul 01; 361:109960.
    View in: PubMed
    Score: 0,015
  42. Pharmacist-initiated antiretroviral therapy (PIMART). S Afr Med J. 2021 12 02; 111(12):1162-1163.
    View in: PubMed
    Score: 0,015
  43. Platelet-inspired therapeutics: current status, limitations, clinical implications, and future potential. Drug Deliv Transl Res. 2021 02; 11(1):24-48.
    View in: PubMed
    Score: 0,014
  44. Three-dimensional printing of extracellular matrix (ECM)-mimicking scaffolds: A critical review of the current ECM materials. J Biomed Mater Res A. 2020 12; 108(12):2324-2350.
    View in: PubMed
    Score: 0,013
  45. Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies. Molecules. 2020 Jul 11; 25(14).
    View in: PubMed
    Score: 0,013
  46. Self-accelerating H2O2-responsive Plasmonic Nanovesicles for Synergistic Chemo/starving therapy of Tumors. Theranostics. 2020; 10(19):8691-8704.
    View in: PubMed
    Score: 0,013
  47. Proteosaccharide combinations for tissue engineering applications. Carbohydr Polym. 2020 May 01; 235:115932.
    View in: PubMed
    Score: 0,013
  48. Bioplatform Fabrication Approaches Affecting Chitosan-Based Interpolymer Complex Properties and Performance as Wound Dressings. Molecules. 2020 Jan 06; 25(1).
    View in: PubMed
    Score: 0,013
  49. Carbon Dots as Nanotherapeutics for Biomedical Application. Curr Pharm Des. 2020; 26(19):2207-2221.
    View in: PubMed
    Score: 0,013
  50. Lipid-drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery. Pharm Dev Technol. 2020 Mar; 25(3):267-280.
    View in: PubMed
    Score: 0,013
  51. The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis. Cells. 2019 10 07; 8(10).
    View in: PubMed
    Score: 0,013
  52. Folate-decorated, endostatin-loaded, nanoparticles for anti-proliferative chemotherapy in esophaegeal squamous cell carcinoma. Biomed Pharmacother. 2019 Nov; 119:109450.
    View in: PubMed
    Score: 0,013
  53. Preprocessing of Medical Image Data for Three-Dimensional Bioprinted Customized-Neural-Scaffolds. Tissue Eng Part C Methods. 2019 07; 25(7):401-410.
    View in: PubMed
    Score: 0,012
  54. Oroactive dental biomaterials and their use in endodontic therapy. J Biomed Mater Res B Appl Biomater. 2020 01; 108(1):201-212.
    View in: PubMed
    Score: 0,012
  55. Synthesis, Characterisation and In Vitro Permeation, Dissolution and Cytotoxic Evaluation of Ruthenium(II)-Liganded Sulpiride and Amino Alcohol. Sci Rep. 2019 03 11; 9(1):4146.
    View in: PubMed
    Score: 0,012
  56. Hypothesis: Can drug-loaded platelets be used as delivery vehicles for blood-brain barrier penetration? Med Hypotheses. 2019 Apr; 125:75-78.
    View in: PubMed
    Score: 0,012
  57. Antineoplastic nano-lipobubbles for passively targeted ovarian cancer therapy. Colloids Surf B Biointerfaces. 2019 May 01; 177:160-168.
    View in: PubMed
    Score: 0,012
  58. 3D scaffolds for brain tissue regeneration: architectural challenges. Biomater Sci. 2018 Oct 24; 6(11):2812-2837.
    View in: PubMed
    Score: 0,012
  59. Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting. Int J Mol Sci. 2018 Oct 04; 19(10).
    View in: PubMed
    Score: 0,012
  60. Functionalizing bioinks for 3D bioprinting applications. Drug Discov Today. 2019 01; 24(1):198-205.
    View in: PubMed
    Score: 0,012
  61. Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions. Artif Cells Nanomed Biotechnol. 2018; 46(sup2):1074-1081.
    View in: PubMed
    Score: 0,012
  62. Therapeutic applications and pharmacoeconomics of microneedle technology. Expert Rev Pharmacoecon Outcomes Res. 2018 08; 18(4):359-369.
    View in: PubMed
    Score: 0,012
  63. Drug Delivery Strategies for Antivirals against Hepatitis B Virus. Viruses. 2018 05 17; 10(5).
    View in: PubMed
    Score: 0,012
  64. Synthesis and biocompatibility of dual-responsive thermosonic injectable organogels based on crosslinked N-(isopropyl acrylamide) for tumour microenvironment targeting. Mater Sci Eng C Mater Biol Appl. 2018 Sep 01; 90:148-158.
    View in: PubMed
    Score: 0,011
  65. 3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery. Eur J Pharm Biopharm. 2019 May; 138:99-110.
    View in: PubMed
    Score: 0,011
  66. Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention. Int J Mol Sci. 2018 Mar 04; 19(3).
    View in: PubMed
    Score: 0,011
  67. Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention. J Cell Mol Med. 2018 03; 22(3):1957-1963.
    View in: PubMed
    Score: 0,011
  68. Outlook on the Application of Metal-Liganded Bioactives for Stimuli-Responsive Release. Molecules. 2017 Nov 26; 22(12).
    View in: PubMed
    Score: 0,011
  69. Synthesis and Evaluation of a Sodium Alginate-4-Aminosalicylic Acid Based Microporous Hydrogel for Potential Viscosupplementation for Joint Injuries and Arthritis-Induced Conditions. Mar Drugs. 2017 Aug 16; 15(8).
    View in: PubMed
    Score: 0,011
  70. Targeted nanotechnologies for cancer intervention: a patent review (2010-2016). Expert Opin Ther Pat. 2017 Sep; 27(9):1005-1019.
    View in: PubMed
    Score: 0,011
  71. Synthesis, Comparison, and Optimization of a Humic Acid-Quat10 Polyelectrolyte Complex by Complexation-Precipitation versus Extrusion-Spheronization. AAPS PharmSciTech. 2017 Nov; 18(8):3116-3128.
    View in: PubMed
    Score: 0,011
  72. Development of an injectable pseudo-bone thermo-gel for application in small bone fractures. Int J Pharm. 2017 Mar 30; 520(1-2):39-48.
    View in: PubMed
    Score: 0,011
  73. The Chemo-Biological Outreach of Nano-Biomaterials: Implications for Tissue Engineering and Regenerative Medicine. Curr Pharm Des. 2017; 23(24):3538-3549.
    View in: PubMed
    Score: 0,010
  74. A Review of Injectable Polymeric Hydrogel Systems for Application in Bone Tissue Engineering. Molecules. 2016 Nov 21; 21(11).
    View in: PubMed
    Score: 0,010
  75. A composite chitosan-gelatin bi-layered, biomimetic macroporous scaffold for blood vessel tissue engineering. Carbohydr Polym. 2017 Feb 10; 157:1215-1225.
    View in: PubMed
    Score: 0,010
  76. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov Today. 2016 12; 21(12):1886-1914.
    View in: PubMed
    Score: 0,010
  77. Stimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular Delivery. Molecules. 2016 Jul 30; 21(8).
    View in: PubMed
    Score: 0,010
  78. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability. Pharm Dev Technol. 2017 Mar; 22(2):283-295.
    View in: PubMed
    Score: 0,010
  79. "On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and Intervention. Int J Mol Sci. 2016 Jul 18; 17(7).
    View in: PubMed
    Score: 0,010
  80. Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
    View in: PubMed
    Score: 0,010
  81. Enhancement of the Oral Bioavailability of Felodipine Employing 8-Arm-Poly(Ethylene Glycol): In Vivo, In Vitro and In Silico Evaluation. AAPS PharmSciTech. 2017 Apr; 18(3):617-628.
    View in: PubMed
    Score: 0,010
  82. Polymeric networks for controlled release of drugs: a patent review. Expert Opin Ther Pat. 2016 Jun; 26(6):703-17.
    View in: PubMed
    Score: 0,010
  83. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain. Int J Pharm. 2016 Mar 16; 500(1-2):196-209.
    View in: PubMed
    Score: 0,010
  84. Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
    View in: PubMed
    Score: 0,010
  85. Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy. Biomed Res Int. 2015; 2015:484963.
    View in: PubMed
    Score: 0,010
  86. Carcinogenic nitrosamines in traditional beer as the cause of oesophageal squamous cell carcinoma in black South Africans. S Afr Med J. 2015 Sep 21; 105(8):656-8.
    View in: PubMed
    Score: 0,010
  87. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015; 10:2191-206.
    View in: PubMed
    Score: 0,009
  88. A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions. J Pharm Pharmacol. 2015 Jul; 67(7):939-50.
    View in: PubMed
    Score: 0,009
  89. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
    View in: PubMed
    Score: 0,009
  90. A review of formulation techniques that impact the disintegration and mechanical properties of oradispersible drug delivery technologies. Pharm Dev Technol. 2016; 21(3):354-66.
    View in: PubMed
    Score: 0,009
  91. Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
    View in: PubMed
    Score: 0,009
  92. Disulphide-thiol chemistry: a multi-faceted tool for macromolecular design and synthesis of polyfunctional materials for specialized drug delivery. Curr Drug Deliv. 2015; 12(3):282-98.
    View in: PubMed
    Score: 0,009
  93. A review of polymeric colloidal nanogels in transdermal drug delivery. Curr Pharm Des. 2015; 21(20):2801-13.
    View in: PubMed
    Score: 0,009
  94. Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects. Curr Pharm Des. 2015; 21(22):3167-80.
    View in: PubMed
    Score: 0,009
  95. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer. Expert Opin Drug Deliv. 2015 Apr; 12(4):613-34.
    View in: PubMed
    Score: 0,009
  96. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules. Biotechnol Adv. 2014 Nov 15; 32(7):1269-1282.
    View in: PubMed
    Score: 0,009
  97. A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury. Biomed Res Int. 2014; 2014:132350.
    View in: PubMed
    Score: 0,009
  98. A comprehensive review of advanced biopolymeric wound healing systems. J Pharm Sci. 2014 Aug; 103(8):2211-30.
    View in: PubMed
    Score: 0,009
  99. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014 Jul 10; 185:130-8.
    View in: PubMed
    Score: 0,009
  100. Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine (Lond). 2014 Feb; 9(2):331-48.
    View in: PubMed
    Score: 0,009
  101. Cur(Que)min: a neuroactive permutation of curcumin and quercetin for treating spinal cord injury. Med Hypotheses. 2014 Apr; 82(4):437-41.
    View in: PubMed
    Score: 0,009
  102. Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine. 2014; 9:589-613.
    View in: PubMed
    Score: 0,009
  103. Patient-controlled analgesia: therapeutic interventions using transdermal electro-activated and electro-modulated drug delivery. J Pharm Sci. 2014 Feb; 103(2):353-66.
    View in: PubMed
    Score: 0,008
  104. Prolonged delivery of ciprofloxacin and diclofenac sodium from a polymeric fibre device for the treatment of periodontal disease. Biomed Res Int. 2013; 2013:460936.
    View in: PubMed
    Score: 0,008
  105. A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014 Feb; 15(1):29-43.
    View in: PubMed
    Score: 0,008
  106. A novel pH-sensitive interferon-ß (INF-ß) oral delivery system for application in multiple sclerosis. Int J Pharm. 2013 Nov 18; 456(2):459-72.
    View in: PubMed
    Score: 0,008
  107. A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye. J Pharm Pharmacol. 2014 Apr; 66(4):490-506.
    View in: PubMed
    Score: 0,008
  108. A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery. Biomed Res Int. 2013; 2013:569470.
    View in: PubMed
    Score: 0,008
  109. Vitamin D therapy and related metabolomics: is the calciferol dose and form the only requirements for successful clinical therapeutics? Med Hypotheses. 2013 Oct; 81(4):656-63.
    View in: PubMed
    Score: 0,008
  110. A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
    View in: PubMed
    Score: 0,008
  111. Design of an anti-inflammatory composite nanosystem and evaluation of its potential for ocular drug delivery. J Pharm Sci. 2013 Aug; 102(8):2780-805.
    View in: PubMed
    Score: 0,008
  112. Integration of biosensors and drug delivery technologies for early detection and chronic management of illness. Sensors (Basel). 2013 Jun 14; 13(6):7680-713.
    View in: PubMed
    Score: 0,008
  113. A review of polymeric refabrication techniques to modify polymer properties for biomedical and drug delivery applications. AAPS PharmSciTech. 2013 Jun; 14(2):692-711.
    View in: PubMed
    Score: 0,008
  114. Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech. 2013 Jun; 14(2):605-19.
    View in: PubMed
    Score: 0,008
  115. Flavonoids and polymer derivatives as CYP3A4 inhibitors for improved oral drug bioavailability. J Pharm Sci. 2013 Feb; 102(2):541-55.
    View in: PubMed
    Score: 0,008
  116. Qualitative and quantitative intravaginal targeting: key to anti-HIV-1 microbicide delivery from test tube to in vivo success. J Pharm Sci. 2012 Jun; 101(6):1950-68.
    View in: PubMed
    Score: 0,008
  117. The application of a crosslinked pectin-based wafer matrix for gradual buccal drug delivery. J Biomed Mater Res B Appl Biomater. 2012 May; 100(4):1029-43.
    View in: PubMed
    Score: 0,007
  118. Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery. Int J Mol Sci. 2011; 12(9):6194-225.
    View in: PubMed
    Score: 0,007
  119. Advanced preformulation investigations for the development of a lead intravaginal bioadhesive polymeric device. Drug Dev Ind Pharm. 2012 Mar; 38(3):271-93.
    View in: PubMed
    Score: 0,007
  120. Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. Expert Opin Drug Deliv. 2011 Oct; 8(10):1323-40.
    View in: PubMed
    Score: 0,007
  121. In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011 Jan 19; 12(1):694-724.
    View in: PubMed
    Score: 0,007
  122. Optimization of a polymer composite employing molecular mechanic simulations and artificial neural networks for a novel intravaginal bioadhesive drug delivery device. Pharm Dev Technol. 2012 Jul-Aug; 17(4):407-20.
    View in: PubMed
    Score: 0,007
  123. Self-assembling peptides: implications for patenting in drug delivery and tissue engineering. Recent Pat Drug Deliv Formul. 2011 Jan; 5(1):24-51.
    View in: PubMed
    Score: 0,007
  124. Ocular drug delivery - a look towards nanobioadhesives. Expert Opin Drug Deliv. 2011 Jan; 8(1):71-94.
    View in: PubMed
    Score: 0,007
  125. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010 Dec; 7(5):370-88.
    View in: PubMed
    Score: 0,007
  126. A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech. 2010 Mar; 11(1):441-59.
    View in: PubMed
    Score: 0,007
  127. Levodopa delivery systems: advancements in delivery of the gold standard. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
    View in: PubMed
    Score: 0,006
  128. Gastroretentive drug delivery systems: current developments in novel system design and evaluation. Curr Drug Deliv. 2009 Oct; 6(5):451-60.
    View in: PubMed
    Score: 0,006
  129. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog Neurobiol. 2009 Aug; 88(4):272-85.
    View in: PubMed
    Score: 0,006
  130. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater. 2009 Apr; 4(2):022001.
    View in: PubMed
    Score: 0,006
  131. Rapidly disintegrating oramucosal drug delivery technologies. Pharm Dev Technol. 2009; 14(6):588-601.
    View in: PubMed
    Score: 0,006
  132. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol. 2009; 14(6):602-12.
    View in: PubMed
    Score: 0,006
  133. A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech. 2008; 9(2):505-20.
    View in: PubMed
    Score: 0,006
  134. Patenting of nanopharmaceuticals in drug delivery: no small issue. Recent Pat Drug Deliv Formul. 2007; 1(2):131-42.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.